Rameshwar S Sidhu

Summary

Affiliation: University of Colorado Health Sciences Center
Country: USA

Publications

  1. ncbi request reprint Midpoint CD34 measurement as a predictor of PBPC product yield in pediatric patients undergoing high-dose chemotherapy
    Rameshwar S Sidhu
    Department of Pathology and Department of Pediatrics Hematology and Oncology Division, University of Colorado Health Sciences Center, The Children s Hospital, Denver, Colorado 80262, USA
    J Clin Apher 21:165-8. 2006
  2. ncbi request reprint Study of coagulation factor activities in apheresed thawed fresh frozen plasma at 1-6 degrees C for five days
    Rameshwar S Sidhu
    Department of Pathology, University of Colorado Health Sciences Center, and The Children s Hospital, Denver, Colorado 80262, USA
    J Clin Apher 21:224-6. 2006

Detail Information

Publications2

  1. ncbi request reprint Midpoint CD34 measurement as a predictor of PBPC product yield in pediatric patients undergoing high-dose chemotherapy
    Rameshwar S Sidhu
    Department of Pathology and Department of Pediatrics Hematology and Oncology Division, University of Colorado Health Sciences Center, The Children s Hospital, Denver, Colorado 80262, USA
    J Clin Apher 21:165-8. 2006
    ..5 of 5 TBV initially set to predict the maximum goal of CD34 cells /kg needed on the same day of PBPC collection; and (3) PBPC collection in pediatric patients <10 kg body weight (as low as 5.8 kg body weight)...
  2. ncbi request reprint Study of coagulation factor activities in apheresed thawed fresh frozen plasma at 1-6 degrees C for five days
    Rameshwar S Sidhu
    Department of Pathology, University of Colorado Health Sciences Center, and The Children s Hospital, Denver, Colorado 80262, USA
    J Clin Apher 21:224-6. 2006
    ..Hence, it is feasible to transfuse the plasma beyond the 24-hour period without compromising the clinical outcome of patients with coagulopathy...